Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study
Author(s) -
Vânia Hungria,
Carlos Chiattone,
Miguel Arturo Pavlovsky,
Lina Abenoza,
G. Ágreda,
Jorge Armenta,
Celso Arrais,
Oscar Avendaño Flores,
Fernando Barroso,
Ana Lisa Basquiera,
Carmen Cao,
María Silvana Cugliari,
Alicia Enrico,
Laura M. Foggliatto,
Kenny Gálvez,
David Gómez Gómez,
Álvaro Gómez,
Daniel de Iracema,
Danielle Farias,
Lineth López,
William Mantilla,
D Rivera Martinez,
Maria Jose Mela,
Carlos E. Miguel,
Roberto Ovilla,
Luis Palmer,
Carolina Pavlovsky,
Christian Omar Ramos Peñafiel,
Guillermina Remaggi,
Rodrigo Santucci,
Sergio Schusterschitz,
Claudia Sossa,
Elena TunaAguilar,
Jorge VelaOjeda,
Telma Santos,
Odin de la Mora,
Gerardo Machnicki,
Mariana Fernandez,
Paula Barreyro
Publication year - 2019
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.19.00025
Subject(s) - medicine , prednisone , rituximab , mantle cell lymphoma , vincristine , chronic lymphocytic leukemia , oncology , epidemiology , lymphoma , cyclophosphamide , chemotherapy , leukemia
Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The primary objective of the Hemato-Oncology Latin America (HOLA) study was to describe patient characteristics and treatment patterns of Latin American patients with MM, CLL, and NHL.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom